Navigation Links
Xenogenics Received Rights to Polyanhydride Compounds Drug Delivery Patent
Date:2/16/2012

ticipate", "estimate", "intend", "plan", "forecast", "could", and "would". MultiCell bases these forward- looking statements on current expectations about future events.  They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement.  Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections in the forward-looking statement include, but are not limited to, the risk that we might not achieve our anticipated clinical development milestones, receive regulatory approval, or successfully commercialize our products as expected, the market for our products will not grow as expected, and the risk that our products will not achieve expectations.  For additional information about risks and uncertainties MultiCell faces, see documents that MultiCell files with the Securities and Exchange Commission, including MultiCell's report on Form 10-K for the fiscal year ended November 30, 2010, and all of MultiCell's quarterly and other periodic SEC filings.  MultiCell claims the protection of the safe harbor for forward-looking statements under the Act and assumes no obligation and expressly disclaims any duty to update any forward-looking statement to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.

 


'/>"/>
SOURCE MultiCell Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts
2. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
3. Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
4. Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation
5. Lotus Pharmaceuticals Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials
6. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
7. Disseminated Adenovirus Infection Eradicated in a Pediatric Hematopoietic Stem Cell Transplantation Recipient Who Received Chimerixs Lead Antiviral CMX001
8. Morphotek, Inc. Announces That Two Investigational Drugs Have Received Orphan Drug Designations
9. Solta Medical Reports FDA Clearance Received for Second Generation LipoSonix® System
10. China Medical Technologies Recently Received Approximately 2,200,000 of its ADSs from Two Banks which Borrowed the ADSs in Connection With the Issuance of the Companys Convertible Notes in August 2008
11. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) ... Technology, Imaging and by Application - Forecast to 2020" report ... expected to reach $13.1 Billion in 2020 from an estimated $7.1 ... The market is dominated by North America , ... , and Rest of the World (RoW). The cancer diagnostics market ...
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... , June 25, 2015 ... has announced the addition of the ... Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape" ... 2015 New Frontiers in Clinical Chemistry and ... is a new seven-country strategic analysis of ...
Breaking Medicine Technology:Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
... (APHY: pinksheets), a leading specialty pharmacy group providing prescription medications ... for the year ended December 31, 2011, an increase of ... 31, 2010.  Basic and diluted net loss per share was ... $2.48 net loss per share in the same period in ...
... Inc. (NYSE: WPI ) today confirmed that ... Delaware has ruled that the asserted claims of United ... ,359 Patent), 7,781,448 (the ,448 Patent), 7,781,449 (the ,449 ... (trospium chloride extended-release capsules) are invalid.  Watson,s Abbreviated New ...
Cached Medicine Technology:Assured Pharmacy Reports Results for the Fiscal Year 2011 2Assured Pharmacy Reports Results for the Fiscal Year 2011 3Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit 2
(Date:7/2/2015)... ... July 02, 2015 , ... The ... Gelatin Capsule manufacturers. The report is a valuable source of guidance and direction ... global and Chinese market for the Gelatin Capsule industry including capacity, production, production ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Dr. Irmgard Neuper is the new General Manager at Catalent’s Schorndorf facility, which ...
(Date:7/2/2015)... ... 02, 2015 , ... Today, East Liverpool City Hospital announced Pam Akin, RN, ... City Hospital (ELCH). Pam is currently the Chief Nursing Officer at ELCH and will ... holds a master’s degree in health care administration as well as nursing. She has ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... introduced CoolSculpting Plus, an advanced approach to body contouring. CoolSculpting Plus ... 44%. , About the basic CoolSculpting procedure:, The CoolSculpting procedure is ...
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, the leader ... announced the release and publication of their newest offering to complement the existing ... Newsletter. , Designed in support of coverage for the full spectrum of ...
Breaking Medicine News(10 mins):Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 2Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 4Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4
... , ... Surgery Specialist Dr. Michael Sundine Helps Children with Facial Deformities , ... Newport Beach, Calif. (Vocus) July 13, ... business focusing on adult cosmetic surgery while also continuing to provide care to children ...
... ... Inc. (ONRAD), is excited to announce the launch of ONRAD,s "Name Our Ant" competition. ... Riverside, CA (PRWEB) July 13, ... Inc. (ONRAD), is excited to announce the launch of ONRAD,s "Name Our Ant" competition. The ...
... The Alzheimer,s Association recognized four scientists for their extraordinary ... Conference on Alzheimer,s Disease (ICAD 2009) in Vienna, Austria. ... "We are beginning to reap the benefits of ... including a robust pipeline of anti-dementia drug therapies and ...
... disease development , SUNDAY, July 12 (HealthDay News) -- A ... risk of developing Alzheimer,s disease and the age at which ... U.S. researchers. , The TOMM40 gene may be the most ... University Medical Center research team, who found that the gene ...
... ... American Orthopaedic Society for Sports Medicine ,s (AOSSM) Annual Meeting in Keystone, Colorado, (July 9-12) ... athletes under the age of 14. , ... Keystone, CO (Vocus) July 12, 2009 -- More and more children are participating ...
... , ACCRA, Ghana, July 11 The Global Health Council ... Parliament in Accra, Ghana, for an integrated and comprehensive American ... , The president,s remarks came after a visit earlier in ... maternal health services provided at the U.S. Agency for International ...
Cached Medicine News:Health News:Top Newport Beach-Based Plastic Surgery Practice Triples Its Revenue; Celebrates Two-Year Anniversary 2Health News:6 scientists receive awards for contributions to Alzheimer's disease research 2Health News:6 scientists receive awards for contributions to Alzheimer's disease research 3Health News:Gene May Help Predict Timing of Alzheimer's Onset 2Health News:Risks of Delaying ACL Reconstruction in Young Athletes May Be Too High, Study Shows 2Health News:Risks of Delaying ACL Reconstruction in Young Athletes May Be Too High, Study Shows 3Health News:Global Health Council Welcomes President Obama's Call in Ghana for Comprehensive Global Health Strategy 2
7 mm blade, angled right. Flat handle....
Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
2.5 mm diameter semi-sharp blade. Referred to as "Large Weapon". Malleable shaft. Round handle. Designated most popular model or size....
7.5 mm curved blade. Referred to as "Number One Knife". Round handle. Designated most popular model or size....
Medicine Products: